V
Virility Medical
Developing intimate skin patch for the treatment of premature ejaculation
About Virility Medical
Virility Medical is a privately held Israeli medical device startup focused on developing treatments for premature ejaculation. The company is in an advanced clinical stage, working on an intimate skin patch that utilizes neuromodulation technology to address this condition. Virility Medical primarily serves men experiencing premature ejaculation, a common sexual dysfunction. Operating in the medical device market, the company aims to provide a non-invasive, effective solution to improve sexual health and quality of life. The business model revolves around the development, clinical testing, and eventual commercialization of its proprietary skin patch. Revenue generation is expected through direct sales and potential partnerships with healthcare providers and distributors.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2016
- Headquarters
- Hod Hasharon, Israel
- Employees
- 8
- Open positions
- None listed
- Dealroom signal
- 76.2/100
- Industry
- Health, Wellness Beauty
- Sub-industry
- BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Skin Care, Tech for Patients, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2c
Latest news
Press, funding announcements and product moves mentioning Virility Medical.
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Jul 2022 | $10M | $40M | Arkin Capital · Migdal Insurance and Financial Holdings | ↗ |
| EARLY VC✓Equity / VC | Feb 2021 | $8M | $32M | Almeda Ventures · Arkin Capital | — |
Growth signals
Latest recorded traffic for Virility Medical is 740 monthly website visits, up 27.6% over the last three months. Virility Medical's team grew 14.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Almeda Ventures
Arkin Capital
Migdal Insurance and Financial Holdings
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Virility Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Virility Medical’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







